Zions Bancorporation N.A. Takes $1.05 Million Position in Stevanato Group S.p.A. (NYSE:STVN)

Zions Bancorporation N.A. bought a new position in shares of Stevanato Group S.p.A. (NYSE:STVN) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 52,462 shares of the company’s stock, valued at approximately $1,049,000.

Other large investors have also bought and sold shares of the company. nVerses Capital LLC acquired a new stake in Stevanato Group in the 3rd quarter valued at $84,000. Hilltop National Bank raised its holdings in shares of Stevanato Group by 34.3% in the 2nd quarter. Hilltop National Bank now owns 4,395 shares of the company’s stock worth $81,000 after acquiring an additional 1,122 shares during the last quarter. Oppenheimer Asset Management Inc. bought a new position in Stevanato Group in the 1st quarter valued at about $241,000. Harbor Capital Advisors Inc. boosted its stake in Stevanato Group by 109.1% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 8,867 shares of the company’s stock valued at $163,000 after purchasing an additional 4,626 shares during the last quarter. Finally, Raymond James Trust N.A. increased its holdings in Stevanato Group by 18.7% during the 2nd quarter. Raymond James Trust N.A. now owns 10,239 shares of the company’s stock worth $188,000 after purchasing an additional 1,613 shares in the last quarter.

Wall Street Analysts Forecast Growth

Separately, Citigroup cut their target price on Stevanato Group from $30.00 to $28.00 and set a “buy” rating on the stock in a research report on Wednesday, August 7th.

Stevanato Group Price Performance

STVN stock opened at €20.50 ($21.81) on Friday. The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. The business has a 50 day moving average of €19.60 and a 200-day moving average of €20.11. Stevanato Group S.p.A. has a 12-month low of €16.56 ($17.62) and a 12-month high of €34.73 ($36.95).

Stevanato Group (NYSE:STVN) last released its earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of €0.13 ($0.14) by (€0.01) (($0.01)). The firm had revenue of €277.90 million during the quarter, compared to analysts’ expectations of €274.36 million. Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The business’s quarterly revenue was up 2.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.16 earnings per share. On average, sell-side analysts predict that Stevanato Group S.p.A. will post 0.5 earnings per share for the current fiscal year.

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.